Interleukin-1β Can Reduce Manifestations of Delayed Effects of Prolonged Exposure to Low-Intensity γ-Radiation
- 作者: Vorobyeva N.1, Grekhova A.1, Trubitsina K.2, Pchelka A.2, Rozhdestevenskiy L.2, Osipov A.2
-
隶属关系:
- Laboratory of Radiation Biophysics, A. I. Burnazyan Federal Medical Biophysical Center, Federal Medical-Biological Agency
- Laboratory of Radiation Pharmacology, A. I. Burnazyan Federal Medical Biophysical Center, Federal Medical-Biological Agency
- 期: 卷 160, 编号 4 (2016)
- 页面: 470-473
- 栏目: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/236738
- DOI: https://doi.org/10.1007/s10517-016-3199-3
- ID: 236738
如何引用文章
详细
We showed that injection of IL-1β (Betaleukin) in a dose of 3 μg/kg 22 h before prolonged (21 h) exposure to low-intensity (10 mGy/min) γ-radiation in a dose of 12.6 Gy reduced the number of double-strand DNA breaks in murine spleen cells to the control level in 4 months after exposure and the number of double-strand DNA breaks induced by additional acute irradiation in a dose of 6 Gy. The results suggest that IL-1β can improve the efficiency of systems reducing the number of double-strand DNA breaks in murine spleen cells at delayed terms after exposure to prolonged low-intensity radiation.
作者简介
N. Vorobyeva
Laboratory of Radiation Biophysics, A. I. Burnazyan Federal Medical Biophysical Center, Federal Medical-Biological Agency
编辑信件的主要联系方式.
Email: nuv.rad@mail.ru
俄罗斯联邦, Moscow
A. Grekhova
Laboratory of Radiation Biophysics, A. I. Burnazyan Federal Medical Biophysical Center, Federal Medical-Biological Agency
Email: nuv.rad@mail.ru
俄罗斯联邦, Moscow
K. Trubitsina
Laboratory of Radiation Pharmacology, A. I. Burnazyan Federal Medical Biophysical Center, Federal Medical-Biological Agency
Email: nuv.rad@mail.ru
俄罗斯联邦, Moscow
A. Pchelka
Laboratory of Radiation Pharmacology, A. I. Burnazyan Federal Medical Biophysical Center, Federal Medical-Biological Agency
Email: nuv.rad@mail.ru
俄罗斯联邦, Moscow
L. Rozhdestevenskiy
Laboratory of Radiation Pharmacology, A. I. Burnazyan Federal Medical Biophysical Center, Federal Medical-Biological Agency
Email: nuv.rad@mail.ru
俄罗斯联邦, Moscow
A. Osipov
Laboratory of Radiation Pharmacology, A. I. Burnazyan Federal Medical Biophysical Center, Federal Medical-Biological Agency
Email: nuv.rad@mail.ru
俄罗斯联邦, Moscow